Current RatioFcf Positive 3yProfitable 3yRevenue Growing 3y
Market Capitalization10.47B HKD
Trailing P/E9.83 HKD
52-Week Change-45.83 HKD
Forward Annual Dividend Yield10.35%
Beta-0.5210 HKD
Ivd Medical Holding Ltd. is a prominent player in the medical equipment sector, specializing in the distribution and provision of in vitro diagnostic products and services. The company primarily focuses on the Chinese market, where it serves healthcare institutions, diagnostic laboratories, and medical professionals with a diverse range of diagnostic systems, reagents, and consumables. Ivd Medical Holding Ltd. is instrumental in enhancing medical diagnostics by ensuring access to high-quality testing solutions, thereby supporting effective healthcare delivery. Its portfolio spans various diagnostic modalities, including immunology, biochemistry, and molecular diagnostics, making it a critical contributor to disease detection and monitoring. In the financial market, the company is recognized for its significant role in advancing healthcare technology and improving public health standards through reliable and efficient diagnostic products. As a hub of innovation and quality in the medical technology space, Ivd Medical Holding Ltd. is pivotal in meeting the growing demand for advanced medical diagnostics in one of the world's largest healthcare markets.
Industry
Medical Distribution
Healthcare sector · China
Stories
Structural patterns identified in Ivd Medical Holding Ltd.
Three cash position signals have aligned: the cash ratio is elevated, cash represents a meaningful portion of assets, and cash exceeds current liabilities by a comfortable margin. Together these indicate substantial liquid resources are present.
cash ratiocash weight
Profit Margin
5.66%
Normal
Mar 18, 2026
Beta
-0.5210HKD
BelowNormalMar 18, 2026
52-Week Change
-45.83HKD
ExtremeMar 18, 2026
Forward Annual Dividend Yield
10.35%
AboveNormalMar 18, 2026
Normal
Mar 18, 2026
Price to Sales (TTM)
0.6139HKD
NormalMar 18, 2026
Price to Book (MRQ)
0.4861HKD
NormalMar 18, 2026
Enterprise to Revenue
1.05HKD
NormalMar 18, 2026
Enterprise to EBITDA
8.17HKD
NormalMar 18, 2026
Profitability & Growth56
Profit Margin
5.66%
NormalMar 18, 2026
Operating Margin
8.98%
NormalMar 18, 2026
Return on Assets (TTM)
0.0403HKD
NormalMar 18, 2026
Return on Equity (TTM)
0.0508HKD
NormalMar 18, 2026
Revenue (TTM)
3.49BHKD
NormalMar 18, 2026
Revenue per Share (TTM)
1.89HKD
NormalMar 18, 2026
Quarterly Revenue Growth
-0.0620HKD
NormalMar 18, 2026
Gross Profit (TTM)
801.37MHKD
NormalMar 18, 2026
EBITDA
487.38MHKD
ExtremeMar 18, 2026
Net Income (TTM)
197.77MHKD
NormalMar 18, 2026
Quarterly Earnings Growth (YoY)
-0.6880HKD
BelowNormalMar 18, 2026
Operating Cash Flow (TTM)
-1.97BHKD
NormalMar 18, 2026
Levered Free Cash Flow (TTM)
-2.22BHKD
NormalMar 18, 2026
Forward Annual Dividend Rate
0.1242HKD
NormalMar 18, 2026
Forward Annual Dividend Yield
10.35%
AboveNormalMar 18, 2026
Trailing Annual Dividend Rate
0.1242HKD
NormalMar 18, 2026
Trailing Annual Dividend Yield
10.35%
AboveNormalMar 18, 2026
5-Year Average Dividend Yield
415.00%
ExtremeMar 18, 2026
Payout Ratio
0.5458HKD
NormalMar 18, 2026
Minority Interest (Equity)
46.57M
NormalFY2024 · Dec 31, 2024
Revenue
3.16B
NormalFY2024 · Dec 31, 2024
Cost of Goods Sold
2.41B
NormalFY2024 · Dec 31, 2024
Gross Profit
751.17M
NormalFY2024 · Dec 31, 2024
Operating Income
461.56M
NormalFY2024 · Dec 31, 2024
Pre-tax Income
401.78M
NormalFY2024 · Dec 31, 2024
Income Tax Expense
135.74M
NormalFY2024 · Dec 31, 2024
Net Income
266.03M
NormalFY2024 · Dec 31, 2024
EBIT
437.76M
NormalFY2024 · Dec 31, 2024
ebitda-income
487.38M
NormalFY2024 · Dec 31, 2024
Selling, General & Administrative
305.14M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Income
2.67M
NormalFY2024 · Dec 31, 2024
Non-operating Interest Expense
35.98M
NormalFY2024 · Dec 31, 2024
EPS (Basic)
0.1742
NormalFY2024 · Dec 31, 2024
EPS (Diluted)
0.1742
NormalFY2024 · Dec 31, 2024
Basic Shares Outstanding
1.50BShares
NormalFY2024 · Dec 31, 2024
Diluted Shares Outstanding
1.50BShares
NormalFY2024 · Dec 31, 2024
Net Income from Continuing Operations
401.78M
NormalFY2024 · Dec 31, 2024
Minority Interests (P&L)
-5.61M
NormalFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00
NormalFY2024 · Dec 31, 2024
Operating Cash Flow
350.26M
NormalFY2024 · Dec 31, 2024
Free Cash Flow
88.69M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
1.77B
NormalFY2024 · Dec 31, 2024
Net Income (CF Statement)
401.78M
NormalFY2024 · Dec 31, 2024
Other Non-cash Items
33.24M
NormalFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
46.10M
NormalFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-130.85M
NormalFY2024 · Dec 31, 2024
Capital Expenditures
-38.83M
NormalFY2024 · Dec 31, 2024
Net Acquisitions
-10.90M
NormalFY2024 · Dec 31, 2024
Sale of Investments
0.00
NormalFY2024 · Dec 31, 2024
Other Investing Activity
-10.40M
NormalFY2024 · Dec 31, 2024
Net Investing Cash Flow
-60.13M
NormalFY2024 · Dec 31, 2024
Long-term Debt Payments
-1.51B
NormalFY2024 · Dec 31, 2024
Net Short-term Debt Issuance
412.34M
NormalFY2024 · Dec 31, 2024
Common Dividends Paid
-140.77M
NormalFY2024 · Dec 31, 2024
Other Financing Charges
-473.00K
NormalFY2024 · Dec 31, 2024
Net Financing Cash Flow
-1.06B
NormalFY2024 · Dec 31, 2024
Financial Strength26
Shares Outstanding
1.62BShares
NormalMar 18, 2026
Float Shares
554.68MHKD
NormalMar 18, 2026
% Held by Insiders
0.6579HKD
NormalMar 18, 2026
% Held by Institutions
0.0010HKD
NormalMar 18, 2026
Total Cash (MRQ)
494.36MHKD
NormalMar 18, 2026
Total Cash per Share (MRQ)
0.2690HKD
NormalMar 18, 2026
Total Debt (MRQ)
1.91BHKD
NormalMar 18, 2026
Total Debt to Equity (MRQ)
47.80HKD
ExtremeMar 18, 2026
Current Ratio (MRQ)
1.79HKD
NormalMar 18, 2026
Book Value per Share (MRQ)
2.43HKD
NormalMar 18, 2026
Total Assets
5.52B
NormalFY2024 · Dec 31, 2024
Total Current Assets
3.72B
NormalFY2024 · Dec 31, 2024
Total Liabilities
1.76B
NormalFY2024 · Dec 31, 2024
Total Non-current Assets
1.81B
NormalFY2024 · Dec 31, 2024
Total Non-current Liabilities
216.03M
NormalFY2024 · Dec 31, 2024
Total Current Liabilities
1.55B
NormalFY2024 · Dec 31, 2024
Cash
1.85B
NormalFY2024 · Dec 31, 2024
Cash Equivalents
7.31M
NormalFY2024 · Dec 31, 2024
Cash & Cash Equivalents
1.77B
NormalFY2024 · Dec 31, 2024
Accounts Receivable
484.28M
NormalFY2024 · Dec 31, 2024
Inventory
1.24B
NormalFY2024 · Dec 31, 2024
Accounts Payable
595.18M
NormalFY2024 · Dec 31, 2024
Short-term Debt
755.97M
NormalFY2024 · Dec 31, 2024
Common Stock (Book)
5.60M
NormalFY2024 · Dec 31, 2024
Retained Earnings
1.17B
NormalFY2024 · Dec 31, 2024
Total Shareholders' Equity
3.76B
NormalFY2024 · Dec 31, 2024
Market & Technical9
52-Week Low
1.09HKD
NormalMar 18, 2026
52-Week High
12.86HKD
NormalMar 18, 2026
52-Week Change
-45.83HKD
ExtremeMar 18, 2026
Beta
-0.5210HKD
BelowNormalMar 18, 2026
50-Day MA
1.57HKD
NormalMar 18, 2026
200-Day MA
4.95HKD
NormalMar 18, 2026
Avg 10-Day Volume
2.12MHKD
NormalMar 18, 2026
Avg 30-Day Volume
4.62MHKD
NormalMar 18, 2026
Diluted EPS (TTM)
0.1200HKD
NormalMar 18, 2026
Screen for dividend patterns
Find other stocks with similar dividend characteristics in the screener.